BioRegenx, Inc. (BRGX)
OTCMKTS · Delayed Price · Currency is USD
0.0080
-0.0010 (-11.11%)
May 13, 2026, 12:24 PM EST
BioRegenx Market Cap
BioRegenx has a market cap or net worth of $7.75 million as of May 14, 2026. Its market cap has decreased by -59.48% in one year.
Market Cap
7.75M
Enterprise Value
9.90M
Revenue
1.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since March 12, 2024, BioRegenx's market cap has decreased from 49.89M to 7.75M, a decrease of -84.46%. That is a compound annual growth rate of -57.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 7.75M | -37.53% |
| Dec 31, 2025 | 12.41M | 44.15% |
| Dec 31, 2024 | 8.61M | -82.74% |
| Mar 12, 2024 | 49.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Retrieve Medical Holdings | 25.56M |
| CareView Communications | 24.52M |
| Veri Medtech Holdings | 23.61M |
| Pharma-Bio Serv | 13.39M |
| PreAxia Health Care Payment Systems | 9.47M |
| CompuMed | 8.84M |
| Vynleads | 7.88M |
| Welsis | 6.85M |